Amy Barone
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Genetics 6
- Glioma Diagnosis and Treatment 6
-
- Childhood Cancer Survivors' Quality of Life 4
- Pharmaceutical studies and practices 3
- Ethics and Legal Issues in Pediatric Healthcare 2
- Co-authors
- Richard Pazdur (7 shared papers)Marc R. Theoret (4 shared papers)Patricia Keegan (3 shared papers)Kun He (3 shared papers)Huanyu Chen (3 shared papers)Kirsten B. Goldberg (2 shared papers)Dow-Chung Chi (2 shared papers)Hong Zhao (4 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Journal of Clinical Oncology (2 papers)Oncotarget (2 papers)Neuro-Oncology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Amy Barone
13 papers receiving 401 citations
Peers
Comparison fields: 5 of 67
- Oncology 183
- Immunology 79
- Cancer Research 51
- Genetics 36
- Biotechnology 22
Countries citing papers authored by Amy Barone
This map shows the geographic impact of Amy Barone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Barone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Barone more than expected).
Fields of papers citing papers by Amy Barone
This network shows the impact of papers produced by Amy Barone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Barone. The network helps show where Amy Barone may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Barone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 114 | |
| 2 | 2017 | 70 | |
| 3 | 2017 | 66 | |
| 4 | 2022 | 38 | |
| 5 | 2014 | 36 | |
| 6 | 2019 | 25 | |
| 7 | 2015 | 15 | |
| 8 | 2017 | 12 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 9 | |
| 11 | 2013 | 8 | |
| 12 | 2017 | 4 | |
| 13 | 2024 | 2 | |
| 14 | 2022 | 0 | |
| 15 | 2026 | 0 |
About Amy Barone
Amy Barone is a scholar working on Genetics, Pediatrics, Perinatology and Child Health, Oncology, Molecular Biology and Neurology, having authored 15 papers that have together received 409 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Pharmaceutical studies and practices (3 papers), Neuroblastoma Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Ethics and Legal Issues in Pediatric Healthcare (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Neurogenesis and neuroplasticity mechanisms (1 paper). The work is most often cited by research in Oncology (183 citations), Immunology (79 citations), Cancer Research (51 citations), Genetics (36 citations) and Biotechnology (22 citations). Amy Barone has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Richard Pazdur, Marc R. Theoret, Patricia Keegan, Kun He, Huanyu Chen, Kirsten B. Goldberg, Dow-Chung Chi, Hong Zhao, Rajeshwari Sridhara and Maitreyee Hazarika. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Oncotarget, Neuro-Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.